{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:50:44Z","timestamp":1777081844449,"version":"3.51.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition with a steadily increasing prevalence. Evidence indicates that both smoking and obesity are significant risk factors for NAFLD, yet the extent to which smoking influences NAFLD through weight gain remains unclear. This study aimed to dissect the intricate relationship between smoking, body mass index (BMI), and NAFLD using Mendelian randomization (MR) analysis. We leveraged data from 30 genome-wide association studies involving over 1.2 million individuals, from which 123 single nucleotide polymorphisms were selected as instrumental variables for smoking. BMI data were sourced from the Genetic Investigation of Anthropometric Traits (GIANT) consortium, encompassing more than 700,000 individuals, with 521 single nucleotide polymorphisms serving as instrumental variables. NAFLD data were obtained from multiple databases, including the eMERGE Network, UK Biobank, Estonian Biobank, and FinnGen, comprising 8434 cases and 770,180 controls. All participants in this study were of European ancestry. We first applied univariate MR analysis to assess the causal relationship between smoking, NAFLD, and BMI. Subsequently, multivariate MR was used to assess the effect of smoking on NAFLD after adjusting for BMI. The coefficient product method was used to calculate the mediating effect of BMI. Results found that both smoking and high BMI were able to increase the risk of NAFLD, with odds ratios of 1.83 (95% confidence interval [CI]: 1.31\u20132.55) and 1.58 (95% CI: 1.42\u20131.77), respectively. BMI mediated 73.3% (95% CI: 62.3%\u201380.5%) of the effect of smoking on NAFLD. The findings support weight control and the encouragement of smoking cessation, especially in obese populations, as strategies to reduce the risk of NAFLD.<\/jats:p>","DOI":"10.1097\/md.0000000000042308","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:27:45Z","timestamp":1746484065000},"page":"e42308","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Mendelian randomization analysis of smoking, BMI, and nonalcoholic fatty liver disease in European descent populations"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9751-244X","authenticated-orcid":false,"given":"Lei","family":"Ma","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China"},{"name":"The First Affiliated Hospital, Guilin Medical University, Guilin, Guangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-2035","authenticated-orcid":false,"given":"Haixing","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanfang","family":"Qu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Guilin Medical University, Guilin, Guangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250513","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease.","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med"},{"key":"R2-20250513","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20250513","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease.","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R4-20250513","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20250513","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R6-20250513","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions.","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20250513","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome.","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R8-20250513","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus.","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-20250513","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease.","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"R10-20250513","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R11-20250513","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrc2703","article-title":"Avoidable global cancer deaths and total deaths from smoking.","volume":"9","author":"Jha","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R12-20250513","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update.","volume":"43","author":"Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250513","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2188\/jea.JE20120067","article-title":"Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China.","volume":"23","author":"Liu","year":"2013","journal-title":"J Epidemiol"},{"key":"R14-20250513","doi-asserted-by":"crossref","first-page":"1015919","DOI":"10.3389\/fpubh.2023.1015919","article-title":"Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score.","volume":"11","author":"Jang","year":"2023","journal-title":"Front Public Health"},{"key":"R15-20250513","doi-asserted-by":"crossref","first-page":"604919","DOI":"10.3389\/fmed.2020.604919","article-title":"Cigarette smoking increased risk of overall mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based cohort study.","volume":"7","author":"Charatcharoenwitthaya","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R16-20250513","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/liv.13701","article-title":"Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease.","volume":"38","author":"Kim","year":"2018","journal-title":"Liver Int"},{"key":"R17-20250513","doi-asserted-by":"crossref","first-page":"6028952","DOI":"10.1155\/2019\/6028952","article-title":"Association between smoking and liver fibrosis among patients with nonalcoholic fatty liver disease.","volume":"2019","author":"Ou","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R18-20250513","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","article-title":"Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.","volume":"54","author":"Zein","year":"2011","journal-title":"J Hepatol"},{"key":"R19-20250513","first-page":"5196","article-title":"Smoking is not associated with nonalcoholic fatty liver disease.","volume":"12","author":"Chavez-Tapia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R20-20250513","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R21-20250513","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R22-20250513","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R23-20250513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R24-20250513","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13679-019-00345-1","article-title":"Nonalcoholic fatty liver disease and obesity treatment.","volume":"8","author":"Brunner","year":"2019","journal-title":"Curr Obes Rep"},{"key":"R25-20250513","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics.","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"R26-20250513","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/oby.2007.153","article-title":"Association of cigarettes smoked daily with obesity in a general adult population.","volume":"15","author":"Chiolero","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"R27-20250513","doi-asserted-by":"crossref","first-page":"e0279443","DOI":"10.1371\/journal.pone.0279443","article-title":"Smoking cessation and obesity-related morbidities and mortality in a 20-year follow-up study.","volume":"17","author":"Suutari-J\u00e4\u00e4sk\u00f6","year":"2022","journal-title":"PLoS One"},{"key":"R28-20250513","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet"},{"key":"R29-20250513","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1017\/S0033291719002678","article-title":"Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study.","volume":"50","author":"Wootton","year":"2020","journal-title":"Psychol Med"},{"key":"R30-20250513","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/sim.2680","article-title":"Modelling smoking history using a comprehensive smoking index: application to lung cancer.","volume":"25","author":"Leffondr\u00e9","year":"2006","journal-title":"Stat Med"},{"key":"R31-20250513","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry.","volume":"27","author":"Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R32-20250513","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease.","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"R33-20250513","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization.","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R34-20250513","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R35-20250513","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R36-20250513","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R37-20250513","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R38-20250513","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia.","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"R39-20250513","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD).","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"R40-20250513","doi-asserted-by":"crossref","first-page":"e84051","DOI":"10.7554\/eLife.84051","article-title":"Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.","volume":"12","author":"Yuan","year":"2023","journal-title":"Elife"},{"key":"R41-20250513","doi-asserted-by":"crossref","first-page":"2050312117745223","DOI":"10.1177\/2050312117745223","article-title":"Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"6","author":"Akhavan Rezayat","year":"2018","journal-title":"SAGE Open Med"},{"key":"R42-20250513","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12887-021-02839-1","article-title":"Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD - an interventional pilot study.","volume":"21","author":"Moran-Lev","year":"2021","journal-title":"BMC Pediatr"},{"key":"R43-20250513","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","article-title":"Cigarette smoking and liver diseases.","volume":"77","author":"Marti-Aguado","year":"2022","journal-title":"J Hepatol"},{"key":"R44-20250513","first-page":"617","article-title":"Smoking and liver disease.","volume":"16","author":"Rutledge","year":"2020","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R45-20250513","doi-asserted-by":"crossref","first-page":"e2200742","DOI":"10.1002\/advs.202200742","article-title":"Hepatic MDM2 causes metabolic associated fatty liver disease by blocking triglyceride-VLDL secretion via ApoB degradation.","volume":"9","author":"Lin","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"R46-20250513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2022.03.001","article-title":"Biomarkers of dysfunctional visceral fat.","volume":"109","author":"Gugliucci","year":"2022","journal-title":"Adv Clin Chem"},{"key":"R47-20250513","doi-asserted-by":"crossref","first-page":"e0148926","DOI":"10.1371\/journal.pone.0148926","article-title":"Association between smoking status and obesity in a nationwide survey of Japanese adults.","volume":"11","author":"Watanabe","year":"2016","journal-title":"PLoS One"},{"key":"R48-20250513","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5993\/AJHB.39.3.5","article-title":"BMI and smoking: interrelated factors among cessation website users.","volume":"39","author":"Schindler-Ruwisch","year":"2015","journal-title":"Am J Health Behav"},{"key":"R49-20250513","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/add.16454","article-title":"Estimating causality between smoking and abdominal obesity by Mendelian randomization.","volume":"119","author":"Carrasquilla","year":"2024","journal-title":"Addiction"},{"key":"R50-20250513","doi-asserted-by":"crossref","first-page":"06","DOI":"10.18332\/tid\/143878","article-title":"Association between waterpipe smoking and obesity: population-based study in Qatar.","volume":"20","author":"Alkeilani","year":"2022","journal-title":"Tob Induc Dis"},{"key":"R51-20250513","doi-asserted-by":"crossref","first-page":"963760","DOI":"10.3389\/fpubh.2022.963760","article-title":"Prevalence of smoking (cigarette and waterpipe) and its association with obesity\/overweight in UAE and Palestine.","volume":"10","author":"Al Sabbah","year":"2022","journal-title":"Front Public Health"},{"key":"R52-20250513","doi-asserted-by":"crossref","first-page":"60","DOI":"10.15420\/ecr.2019.4.2","article-title":"Obesity and cardiovascular risk after quitting smoking: the latest evidence.","volume":"14","author":"Hasegawa","year":"2019","journal-title":"Eur Cardiol"},{"key":"R53-20250513","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.toxlet.2013.04.019","article-title":"Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.","volume":"220","author":"Oniki","year":"2013","journal-title":"Toxicol Lett"},{"key":"R54-20250513","first-page":"E102","article-title":"Non-alcoholic fatty liver disease is strongly associated with smoking status and is improved by smoking cessation in Japanese males: a retrospective study.","volume":"66","author":"Takenaka","year":"2020","journal-title":"Kobe J Med Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:04:26Z","timestamp":1747173866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":54,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042308","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}